Age group, yr |
< 45 | 1365 (20.4) | 1247 (20.1) | 0.05 |
45–64 | 2642 (39.4) | 2588 (41.8) | |
65–79 | 1753 (26.2) | 1563 (25.2) | |
≥ 80 | 942 (14.1) | 797 (12.9) | |
Sex | | | |
Female | 3444 (51.4) | 3155 (50.9) | 0.01 |
Male | 3258 (48.6) | 3040 (49.1) | |
No. of unique nonopioid medications, median (IQR) | 6 (3–9) | 6 (3–9) | −0.02 |
Dispensing characteristics for oxycodone CR |
Maximum strength dispensed, mg |
10–30 | 5143 (76.7) | 4694 (75.8) | 0.02 |
40–80 | 1559 (23.3) | 1501 (24.2) | |
No. of dispensings per participant, median (IQR) | 3 (2–5) | 3 (2–5) | 0.02 |
Other medications with sedative properties co-dispensed within 30 d of oxycodone CR |
Antipsychotic | 474 (7.1) | 442 (7.1) | 0.002 |
Benzodiazepine | 1945 (29.0) | 1819 (29.4) | 0.08 |
Serotonin–norepinephrine reuptake inhibitor | 858 (12.8) | 817 (13.2) | 0.01 |
Tricyclic antidepressant | 966 (14.4) | 887 (14.3) | −0.003 |